(1)
Bevacizumab in Advanced High Grade Serous Ovarian Cancer: The Impact of BRCA Mutation Status. J. Can. Res. Updates 2026, 15 (1), 1-10. https://doi.org/10.30683/1929-2279.2026.15.01.